Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Methods Mol Biol ; 2517: 229-240, 2022.
Article En | MEDLINE | ID: mdl-35674958

Antifungal resistance mediated by overexpression of ABC transporters is one of the primary roadblocks to effective therapy against Candida infections. Thus, identification and characterization of the ABC transporter repertoire in Candida species are of high relevance. The method described in the chapter is based on our previously developed bioinformatic pipeline for identification of ABC proteins in Candida species. The methodology essentially involves the utilization of a hidden Markov model (HMM) profile of the nucleotide-binding domain (NBD) of ABC proteins to mine these proteins from the proteome of Candida species. Further, a widely used tool to predict membrane protein topology is exploited to identify the true transporter candidates out of the ABC proteins. Even though the chapter specifically focuses on a method to identify ABC transporters in Candida auris , the same can also be applied to any other Candida species.


ATP-Binding Cassette Transporters , Candida auris , Computational Biology , ATP-Binding Cassette Transporters/metabolism , Antifungal Agents/pharmacology , Candida auris/genetics , Candida auris/metabolism , Drug Resistance, Fungal
2.
ACS Infect Dis ; 8(3): 584-595, 2022 03 11.
Article En | MEDLINE | ID: mdl-35179882

Candida auris is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat C. auris. Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of host immunity. Cu-only SODs are essential for the virulence of diverse fungal pathogens; however, little is understood about these enzymes in C. auris. We show here that C. auris secretes an enzymatically active Cu-only SOD (CaurSOD4) when cells are starved for Fe, a condition mimicking host environments. Although predicted to attach to cell walls, CaurSOD4 is detected as a soluble extracellular enzyme and can act at a distance to remove superoxide. CaurSOD4 selectively binds Cu and not Zn, and Cu binding is labile compared to bimetallic Cu/Zn SODs. Moreover, CaurSOD4 is susceptible to inhibition by various metal-binding drugs that are without effect on mammalian Cu/Zn SODs. Our studies highlight CaurSOD4 as a potential antifungal target worthy of consideration.


Antifungal Agents , Candida auris , Drug Resistance, Multiple, Fungal , Superoxide Dismutase , Animals , Antifungal Agents/pharmacology , Candida auris/drug effects , Candida auris/enzymology , Candida auris/metabolism , Candida auris/pathogenicity , Copper/metabolism , Drug Resistance, Multiple, Fungal/drug effects , Drug Resistance, Multiple, Fungal/physiology , Mammals/metabolism , Superoxide Dismutase/metabolism , Virulence/physiology , Zinc/metabolism
3.
Microbiol Spectr ; 9(3): e0153821, 2021 12 22.
Article En | MEDLINE | ID: mdl-34908466

Emerging and reemerging pathogens are a worldwide concern, and it is predicted that these microbes will cause severe outbreaks. Candida auris affects people with weakened immune systems, particularly those who are hospitalized or are in health care facilities. Extracellular vesicles (EVs) are lipid bilayer structures released by organisms from all domains of life. EVs can deliver functional molecules to target cells, including proteins and nucleic acids, especially RNA molecules. EVs from several pathogenic fungi species play diverse biological roles related to cell-cell communication and pathogen-host interaction. In this study, we describe a data set which we produced by sequencing the RNA content of EVs from C. auris under normal growth conditions and in the presence of the antifungal caspofungin, a first-line drug to treat this fungus. To generate a more complete data set for future comparative studies, we also sequenced the RNA cellular content of EVs under the same conditions. This data set addresses a previously unexplored area of fungal biology regarding cellular small RNA and EV RNA. Our data will provide a molecular basis for the study of the aspects associated with antifungal treatment, gene expression response, and EV composition in C. auris. These data will also allow the exploration of small RNA content in the fungal kingdom and might serve as an informative basis for studies on the mechanisms by which molecules are directed to fungal EVs. IMPORTANCE Candida auris, a relevant emerging human-pathogenic yeast, is the first fungus to be called a global public health threat by the WHO. This is because of its rapid spread on all inhabited continents, together with its extremely high frequency of drug and multidrug resistance. In our study, we generated a large data set for 3 distinct strains of C. auris and obtained cellular small RNA fraction as well as extracellular vesicle RNA (EV-RNA) during normal growth conditions and after treatment with caspofungin, the first-line drug used to treat C. auris infection.


Antifungal Agents/pharmacology , Candida auris/drug effects , Candida auris/metabolism , Extracellular Vesicles/metabolism , RNA/metabolism , Candida auris/genetics , Candidiasis, Invasive/drug therapy , Diagnostic Tests, Routine , Fungi/genetics , Genetic Techniques , Host-Pathogen Interactions , Humans , Microbial Sensitivity Tests
4.
mSphere ; 6(3): e0040621, 2021 06 30.
Article En | MEDLINE | ID: mdl-34160238

Candida auris, a recently emergent fungal pathogen, has caused invasive infections in health care settings worldwide. Mortality rates approach 60% and hospital spread poses a public health threat. Compared to other Candida spp., C. auris avoids triggering the antifungal activity of neutrophils, innate immune cells that are critical for responding to many invasive fungal infections, including candidiasis. However, the mechanism underpinning this immune evasion has been largely unknown. Here, we show that C. auris cell wall mannosylation contributes to the evasion of neutrophils ex vivo and in a zebrafish infection model. Genetic disruption of mannosylation pathways (PMR1 and VAN1) diminishes the outer cell wall mannan, unmasks immunostimulatory components, and promotes neutrophil engagement, phagocytosis, and killing. Upon examination of these pathways in other Candida spp. (Candida albicans and Candida glabrata), we did not find an impact on neutrophil interactions. These studies show how C. auris mannosylation contributes to neutrophil evasion though pathways distinct from other common Candida spp. The findings shed light on innate immune evasion for this emerging pathogen. IMPORTANCE The emerging fungal pathogen Candida auris presents a global public health threat. Therapeutic options are often limited for this frequently drug-resistant pathogen, and mortality rates for invasive disease are high. Previous study has demonstrated that neutrophils, leukocytes critical for the antifungal host defense, do not efficiently recognize and kill C. auris. Here, we show how the outer cell wall of C. auris promotes immune evasion. Disruption of this mannan polysaccharide layer renders C. auris susceptible to neutrophil killing ex vivo and in a zebrafish model of invasive candidiasis. The role of these mannosylation pathways for neutrophil evasion appears divergent from other common Candida species.


Candida albicans/immunology , Candida auris/immunology , Candida auris/metabolism , Candida glabrata/immunology , Cell Wall/metabolism , Immune Evasion , Mannans/metabolism , Neutrophils/immunology , Animals , Candida auris/genetics , Candida auris/pathogenicity , Neutrophils/microbiology , Phagocytosis , Virulence , Zebrafish/microbiology
...